Advertisement
Screener

INCYTE CORPORATION (INCY) Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale

INCYTE CORPORATION Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale

INCYTE CORPORATION (INCY) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $860.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-21.

Discontinued › Cash Flow › Investing Activities

us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2013-02-21

  • INCYTE CORPORATION proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2012 was $860.00K, a 33.74% decline from fiscal 2011.
  • INCYTE CORPORATION proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2011 was $1.30M, a 93.13% decline from fiscal 2010.
  • INCYTE CORPORATION proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2010 was $18.88M, a 20.83% increase from fiscal 2009.
  • INCYTE CORPORATION proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2009 was $15.63M.
Period endProceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month
2012-12-31$860.00K
10-K · filed 2013-02-21
2011-12-31$1.30M
10-K · filed 2013-02-21
2010-12-31$18.88M
10-K · filed 2013-02-21
2009-12-31$15.63M
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
IQVIA HOLDINGS INC. (IQV)United States$45.926B20.54
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B